Cited 0 times in Scipus Cited Count

Hesperetin inhibit EMT in TGF-beta treated podocyte by regulation of mTOR pathway

Authors
Choi, D | Kim, CL | Kim, JE | Mo, JS  | Jeong, HS
Citation
Biochemical and biophysical research communications, 528(1). : 154-159, 2020
Journal Title
Biochemical and biophysical research communications
ISSN
0006-291X1090-2104
Abstract
Renal fibrosis is one of the characteristic features of chronic kidney disease (CKD). Fibrotic change not only impairs the filtration function of the kidney but is also recognized as a marker of end-stage renal disease (ESRD). The epithelial to mesenchymal transition (EMT) is known to play a role in embryonic development and organ formation, but it is getting much attention for its pathological role in the invasion and metastasis of carcinoma. Recently, it has also been reported that EMT plays a role in the formation of fibrosis during chronic inflammation. EMT contribute to the development of the fibrosis in CKD. Moreover, glomerular podocytes and tubular epithelial cells can also undergo mesenchymal transition in CKD. Hesperetin is a flavonoid present in citrus and is well known for its antioxidant and anti-inflammatory properties. In this study, we investigated the effects of hesperetin on the EMT-elicited podocytes. First, we generated an EMT model by treating transforming growth factor (TGF)-beta1, a potent inducer of EMT to the podocytes. TGF-beta1 decreased the expression of epithelial markers such as nephrin, zonula occludens-1 (ZO-1), while it increased the mesenchymal markers, including fibronectin (FN), vimentin, and alpha-smooth muscle actin (alpha-SMA) in the podocytes. Hesperetin suppressed EMT-like changes elicited by TGF-beta1. Interestingly, hesperetin did not interfere with the Smad signaling-the classical TGF-beta signaling-pathway, which was confirmed by the experiment with smad 2/3 -/- podocytes. Instead, hesperetin suppressed EMT-like changes by inhibiting the mTOR pathway-one of the alternative TGF-beta signaling pathways. In conclusion, hesperetin has a protective effect on the TGF-beta1 elicited EMT-like changes of podocytes through regulation of mTOR pathway. It could be a good candidate for the suppression of kidney fibrosis in various CKD.
Keywords

MeSH

DOI
10.1016/j.bbrc.2020.05.087
PMID
32451085
Appears in Collections:
Journal Papers > Research Organization > Institute for Medical Sciences
Ajou Authors
모, 정순
Files in This Item:
There are no files associated with this item.
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse